SCHEMBL30220101

SCHEMBL30220101

C1=Nc2cscc2CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29546867 0.68 TRPA1 (0.41)
Water SCHEMBL28834494 0.67 TRPA1 (0.39)
Hydrochloric Acid SCHEMBL30528593 0.67 NPC1 (0.43)
SCHEMBL29484156 0.65
SCHEMBL29541803 0.64 CHRNB2 (0.42)
SCHEMBL29077369 0.64 CHRNB2 (0.42)
SCHEMBL24783963 0.63 MEN1 (0.37)
SCHEMBL15120307 0.63 HTR5A (0.35)
SCHEMBL29809502 0.63 CYP2D6 (0.33)
SCHEMBL30843932 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12162890-B2 Heteroaromatic NMDA receptor modulators and uses thereof NOVARTIS AG (CH) 2024-12-10 US disclosed
US-20230023543-A1 HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF NOVARTIS AG (CH) 2023-01-26 US disclosed